Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Research Coverage on Small and Micro-Cap Companies

Equity Bottom-Up

Oramed Pharmaceuticals  / Equity Bottom-Up

<ul><li> ORMP expects to fund and manage an upcoming clinical trial that builds on earlier Phase 2 and Phase 3 trials it conducted.</li><li>Separately, ORMP has leveraged its balance sheet to make investments in multiple companies, while concurrently advancing its strategy to move its technology and assets forward.</li><li>In the aggregate, these investments have yielded solid returns that funded a recent dividend payment to ORMP shareholders.</li></ul>

 ORMP expects to fund and manage an upcoming clinical trial that builds on earlier Phase 2 and Phase 3 trials it conducted.Separately, ORMP has leveraged its balance sheet to make investments in multiple companies, while concurrently advancing its strategy to move its technology and assets forward.In the aggregate, these investments have yielded solid returns that funded a recent dividend payment to ORMP shareholders.

ORMP: Enabling Participation in Both ORMP & LFWD Businesses Expected to Enhance Shareholder Value